Array BioPharma to Present at the Leerink Swann & Company Cancer Medicines on the Horizon Conference

    BOULDER, Colo., Sept. 14 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
 (Nasdaq:   ARRY) today announced that its Chief Executive Officer, Robert E.
 Conway, will speak at the Leerink Swann & Company Cancer Medicines on the
 Horizon Conference on September 18 in New York City. The public is welcome
 to participate in the conference through an audio webcast on the Array
 BioPharma website.
     Event:          Leerink Swann & Company Cancer Medicines on the Horizon
     Presenter:      Robert E. Conway, Chief Executive Officer, Array BioPharma
     Date:           Monday, September 18, 2006
     Time:           10:15 am Eastern Time
     Location:       Le Parker Meridien, New York City
     Audio Webcast:
     Additionally, Array's President and Chief Scientific Officer, Kevin
 Koch, Ph.D., will speak on an expert panel entitled "New Therapy" during
 the conference.
     About Array BioPharma:
     Array BioPharma Inc. is a biopharmaceutical company focused on the
 discovery, development and commercialization of targeted small molecule
 drugs to treat life threatening and debilitating diseases. Our proprietary
 drug development pipeline is focused on the treatment of cancer and
 inflammatory disease and includes clinical candidates that are designed to
 regulate therapeutically important targets. In addition, leading
 pharmaceutical and biotechnology companies collaborate with Array to
 discover and develop drug candidates across a broad range of therapeutic
 areas. For more information on Array, please go to

SOURCE Array BioPharma Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.